Featured Publications

2025

2020-2024

  • Cao S, Pan Y, Terker AS, Arroyo Ornelas JP, Wang Y, Tang J, Niu A, Kar SA, Jiang M, Luo W, Dong X, Fan X, Wang S, Wilson MH, Fogo A, Zhang MZ, Harris RC. Epidermal growth factor receptor activation is essential for kidney fibrosis development. Nat Commun. 2023 Nov 14;14(1):7357. doi: 10.1038/s41467-023-43226-x. PMID: 37963889.
  • Kenigsberg Z, Welch RC, Bejoy J, Williams FM, Veach RA, Jarrett I, Thompson TK, Wilson MH, Woodard LE. Genome engineering of human urine-derived stem cells to express lactoferrin and deoxyribonuclease. Tissue Eng Part A. 2023 May 2. doi: 10.1089/ten.TEA.2023.0003. Epub ahead of print. PMID: 37130035.
  • Peek JL, Wilson MH. Cell and gene therapy for kidney disease. Nat Rev Nephrol. 2023 Mar 27. doi: 10.1038/s41581-023-00702-3. Epub ahead of print. PMID: 36973494. Luo W, Hickman AB, Genzor P, Ghirlando R, Furman CM, Menshikh A, Haase A, Dyda F, Wilson MH. Transposase N-terminal phosphorylation and asymmetric transposon ends inhibit piggyBac transposition in mammalian cells. Nucleic Acids Res. 2022 Dec 9;50(22):13128-13142. doi: 10.1093/nar/gkac1191. PMID: 36537219; PMCID: PMC9825180.
  • Wentian Luo, Alison B. Hickman, Pavol Genzor, Rodolfo Ghirlando, Christopher M. Furman, Anna Menshikh, Astrid Haase, Fred Dyda, Matthew H. Wilson. Transposase N-terminal phosphorylation and asymmetric transposon ends inhibit piggyBac transposition in mammalian cells. bioRxiv 2022.09.26.509586; doi: https://doi.org/10.1101/2022.09.26.509586
  • Arroyo JP, Terker AS, Zuchowski Y, Watts JA, Bock F, Meyer C, Luo W, Kapp ME, Gould ER, Miranda AX, Carty J, Jiang M, Vanacore RM, Hammock E, Wilson MH, Zent R, Zhang M, Bhave G, Harris RC. Kidney collecting duct cells make vasopressin in response to NaCl induced hypertonicity. JCI Insight. 2022 Nov 3;. doi: 10.1172/jci.insight.161765. [Epub ahead of print] PubMed PMID: 36326835.
  • Hunter K, Larsen JA, Love HD, Evans RC, Roy S, Zent R, Harris R, Wilson MH, Fissell WH. Inhibition of TGF-β improves primary renal tubule cell differentiation in long-term culture. Tissue Eng Part A. 2022 Oct 23;. doi: 10.1089/ten.TEA.2022.0147. [Epub ahead of print] PubMed PMID: 36274231.
  • Haake SM, Plosa EJ, Kropski JA, Venton LA, Reddy A, Bock F, Chang BT, Luna AJ, Nabukhotna K, Xu ZQ, Prather RA, Lee S, Tanjore H, Polosukhin VV, Viquez OM, Jones A, Luo W, Wilson MH, Rathmell WK, Massion PP, Pozzi A, Blackwell TS, Zent R. Ligand-independent integrin β1 signaling supports lung adenocarcinoma development. JCI Insight. 2022 Aug 8;7(15). doi: 10.1172/jci.insight.154098. PubMed PMID: 35763345; PubMed Central PMCID: PMC9462485.
  • Peek JL, Wilson MH. Gene therapy for kidney disease: targeting cystinuria. Curr Opin Nephrol Hypertens. 2021 Dec 15. doi: 10.1097/MNH.0000000000000768. Epub ahead of print. PMID: 34982522.
  • Pan Y, Cao S, Terker AS, Tang J, Sasaki K, Wang Y, Niu A, Luo W, Fan X, Wang S, Wilson MH, Zhang MZ, Harris RC. Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury. Kidney Int. 2022 Jan;101(1):79-91. doi: 10.1016/j.kint.2021.09.033. Epub 2021 Nov 11. PMID: 34774558; PMCID: PMC8741730.
  • Wilson MH, Gottschalk S. Expect the unexpected: piggyBac and lymphoma. Blood. 2021 Oct 21;138(16):1379-1380. doi: 10.1182/blood.2021012349. PMID: 34673949.
  • Beckermann TM, Luo W, Wilson CM, Veach RA, Wilson MH. Cognate restriction of transposition by piggyBac-like proteins. Nucleic Acids Res. 2021 Jul 7:gkab578. doi: 10.1093/nar/gkab578. Epub ahead of print. PMID: 34232995.
  • Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, Sugiura A, Cohen AS, Ali A, Do BT, Muir A, Lewis CA, Hongo RA, Young KL, Brown RE, Todd VM, Huffstater T, Abraham A, O'Neil RT, Wilson MH, Xin F, Tantawy MN, Merryman WD, Johnson RW, Williams CS, Mason EF, Mason FM, Beckermann KE, Vander Heiden MG, Manning HC, Rathmell JC, Rathmell WK. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature. 2021 Apr 7. doi: 10.1038/s41586-021-03442-1. Epub ahead of print. PMID: 33828302.
  • Woodard LE, Williams FM, Jarrett IC, Wilson MH. Functional analysis of the catalytic triad of the hAT-family transposase TcBuster. Plasmid. 2021 Mar;114:102554. doi: 10.1016/j.plasmid.2021.102554. Epub 2021 Jan 18. PMID: 33476638; PMCID: PMC7946762.
  • Reinfeld BI, Madden MZ, Wolf MM, Chytil A, Bader JE, Patterson AR, Cohen AS, Ali A, Do BT, Muir A, Lewis CA, Hongo RA, Young KL, Brown RE, Todd VM, Huffstater T, Abraham A, O’Neil RT, Wilson MH, Xin F, Tantawy MN, Merryman WD, Johnson RW, Williams CS, Mason EF, Mason FM, Beckermann KE, Vander Heiden MG, Manning HC, Rathmell JC, Rathmell WK. Cell Programmed Nutrient Partitioning in the Tumor Microenvironment. bioRxiv 2020.08.10.238428.
  • Chiusa M, Hu W, Zienkiewicz J, Chen X, Zhang MZ, Harris RC, Vanacore RM, Bentz JA, Remuzzi G, Benigni A, Fogo AB, Luo W, Mili S, Wilson MH, Zent R, Hawiger J, Pozzi A. EGF receptor-mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling. Journal of Cell Biology. 2020, 219(9):e202001120.
  • Chen Q, Luo W, Veach RA, Hickman AB, Wilson MH, Dyda F. Structural basis of seamless excision and specific targeting by piggyBac transposase. Nat Commun. 2020;11(1):3446. Published 2020 Jul 10. doi:10.1038/s41467-020-17128-1
  • Love HD, Evans RC, Humes HD, Roy S, Zent R, Harris R, Wilson MH, Fissell WH. Metformin and Inhibition of TGF-β Stimulate In Vitro Transport in Primary Renal Tubule Cells. Tissue Eng Part A. 2020 Apr 20;. doi: 10.1089/ten.TEA.2019.0294. [Epub ahead of print] PubMed PMID: 32312181.
  • Beckermann TM, Welch RC, Williams FM, Mortlock DP, Sha F, Ikizler TA, Woodard LE, Wilson MH. CRISPR/Cas9 engineering of albino cystinuria Type A mice. Genesis. 2020 Feb 20:e23357. doi: 10.1002/dvg.23357. [Epub ahead of print] PMID: 32078250
  • Wilson MH, Veach RA, Luo W, Welch RC, Roy S, Fissell WH. Genome Engineering Renal Epithelial Cells for Enhanced Volume Transport Function. Cell Mol Bioeng. 2019 Sep 25;13(1):17-26. doi: 10.1007/s12195-019-00601-3. eCollection 2020 Feb. PMID: 32030105
  • Woodard LE, Welch RC, Veach RA, Beckermann TM, Sha F, Weinman EJ, Ikizler TA, Tischfield JA, Sahota A, Wilson MH. Metabolic consequences of cystinuria. BMC Nephrol. 2019 Jun 20;20(1):227. doi: 10.1186/s12882-019-1417-8. PubMed PMID: 31221135; PubMed Central PMCID: PMC6585015.
  • Saito S, Nakazawa Y, Sueki A, Matsuda K, Tanaka M, Yanagisawa R, Maeda Y, Sato Y, Okabe S, Inukai T, Sugita K, Wilson MH, Rooney CM, Koike K. Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Cytotherapy. 2014 Sep;16(9):1257-69. doi: 10.1016/j.jcyt.2014.05.022. PubMed PMID: 25108652; PubMed Central PMCID: PMC4948190.
  • Galvan DL, Kettlun CS, Wilson MH. Targeting piggyBac transposon integrations in the human genome. Methods Mol Biol. 2014;1114:143-61. doi: 10.1007/978-1-62703-761-7_9. PubMed PMID: 24557901.
  • Doherty JE, Woodard LE, Bear AS, Foster AE, Wilson MH. An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression. FASEB J. 2013 Sep;27(9):3753-62. doi: 10.1096/fj.13-232090. Epub 2013 Jun 10. PubMed PMID: 23752206; PubMed Central PMCID: PMC3752539.
  • Saha S, Wilson MH. Transposons for Non-Viral Gene Transfer . In: Gene Therapy - Tools and Potential Applications. Molina FM, editor. www.intechopen.com: InTech; 2013. p.269-285.
  • Nakazawa Y, Saha S, Galvan DL, Huye L, Rollins L, Rooney CM, Wilson MH. Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. J Immunother. 2013 Jan;36(1):3-10. doi: 10.1097/CJI.0b013e3182791234. PubMed PMID: 23211626; PubMed Central PMCID: PMC3521868.
  • Liang A, Wang Y, Woodard LE, Wilson MH, Sharma R, Awasthi YC, Du J, Mitch WE, Cheng J. Loss of glutathione S-transferase A4 accelerates obstruction-induced tubule damage and renal fibrosis. J Pathol. 2012 Dec;228(4):448-58. doi: 10.1002/path.4067. Epub 2012 Jul 26. PubMed PMID: 22711583; PubMed Central PMCID: PMC3760987.
  • Woodard LE, Li X, Malani N, Kaja A, Hice RH, Atkinson PW, Bushman FD, Craig NL, Wilson MH. Comparative analysis of the recently discovered hAT transposon TcBuster in human cells. PLoS One. 2012;7(11):e42666. doi: 10.1371/journal.pone.0042666. Epub 2012 Nov 15. PubMed PMID: 23166581; PubMed Central PMCID: PMC3499496.
  • Saha S, Nakazawa Y, Huye LE, Doherty JE, Galvan DL, Rooney CM, Wilson MH. piggyBac transposon system modification of primary human T cells. J Vis Exp. 2012 Nov 5;(69):e4235. doi: 10.3791/4235. PubMed PMID: 23149543; PubMed Central PMCID: PMC3514050.
  • Doherty JE, Huye LE, Yusa K, Zhou L, Craig NL, Wilson MH. Hyperactive piggyBac gene transfer in human cells and in vivo. Hum Gene Ther. 2012 Mar;23(3):311-20. doi: 10.1089/hum.2011.138. Epub 2011 Dec 14. PubMed PMID: 21992617; PubMed Central PMCID: PMC3300075.
  • Nakazawa Y, Huye LE, Salsman VS, Leen AM, Ahmed N, Rollins L, Dotti G, Gottschalk SM, Wilson MH, Rooney CM. PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor. Mol Ther. 2011 Dec;19(12):2133-43. doi: 10.1038/mt.2011.131. Epub 2011 Jul 19. PubMed PMID: 21772253; PubMed Central PMCID: PMC3242651.
  • Huye LE, Nakazawa Y, Patel MP, Yvon E, Sun J, Savoldo B, Wilson MH, Dotti G, Rooney CM. Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination. Mol Ther. 2011 Dec;19(12):2239-48. doi: 10.1038/mt.2011.179. Epub 2011 Aug 30. PubMed PMID: 21878902; PubMed Central PMCID: PMC3242659.
  • Kettlun C, Galvan DL, George AL Jr, Kaja A, Wilson MH. Manipulating piggyBac transposon chromosomal integration site selection in human cells. Mol Ther. 2011 Sep;19(9):1636-44. doi: 10.1038/mt.2011.129. Epub 2011 Jul 5. PubMed PMID: 21730970; PubMed Central PMCID: PMC3182353.
  • Wang J, Wang Y, Long J, Chang BH, Wilson MH, Overbeek P, Danesh FR. Tamoxifen-inducible podocyte-specific iCre recombinase transgenic mouse provides a simple approach for modulation of podocytes in vivo. Genesis. 2010 Jul;48(7):446-51. doi: 10.1002/dvg.20635. PubMed PMID: 20641128; PubMed Central PMCID: PMC3014324.
  • Manuri PV, Wilson MH, Maiti SN, Mi T, Singh H, Olivares S, Dawson MJ, Huls H, Lee DA, Rao PH, Kaminski JM, Nakazawa Y, Gottschalk S, Kebriaei P, Shpall EJ, Champlin RE, Cooper LJ. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum Gene Ther. 2010 Apr;21(4):427-37. doi: 10.1089/hum.2009.114. PubMed PMID: 19905893; PubMed Central PMCID: PMC2938363.
  • Kahlig KM, Saridey SK, Kaja A, Daniels MA, George AL Jr, Wilson MH. Multiplexed transposon-mediated stable gene transfer in human cells. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1343-8. doi: 10.1073/pnas.0910383107. Epub 2010 Jan 6. PubMed PMID: 20080581; PubMed Central PMCID: PMC2824351.
  • Wilson MH, George AL Jr. Designing and testing chimeric zinc finger transposases. Methods Mol Biol. 2010;649:353-63. doi: 10.1007/978-1-60761-753-2_22. PubMed PMID: 20680846.
  • Saridey SK, Liu L, Doherty JE, Kaja A, Galvan DL, Fletcher BS, Wilson MH. PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol Ther. 2009 Dec;17(12):2115-20. doi: 10.1038/mt.2009.234. Epub 2009 Oct 6. PubMed PMID: 19809403; PubMed Central PMCID: PMC2814386.
  • Nakazawa Y, Huye LE, Dotti G, Foster AE, Vera JF, Manuri PR, June CH, Rooney CM, Wilson MH. Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytes. J Immunother. 2009 Oct;32(8):826-36. doi: 10.1097/CJI.0b013e3181ad762b. PubMed PMID: 19752751; PubMed Central PMCID: PMC2796278.
  • Galvan DL, Nakazawa Y, Kaja A, Kettlun C, Cooper LJ, Rooney CM, Wilson MH. Genome-wide mapping of PiggyBac transposon integrations in primary human T cells. J Immunother. 2009 Oct;32(8):837-44. doi: 10.1097/CJI.0b013e3181b2914c. PubMed PMID: 19752750; PubMed Central PMCID: PMC2796288.
  • Wilson MH, Coates CJ, George AL Jr. PiggyBac transposon-mediated gene transfer in human cells. Mol Ther. 2007 Jan;15(1):139-45. doi: 10.1038/sj.mt.6300028. PubMed PMID: 17164785.
  • Tan CM, Wilson MH, MacMillan LB, Kobilka BK, Limbird LE. Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12471-6. doi: 10.1073/pnas.122368499. Epub 2002 Aug 30. PubMed PMID: 12205290; PubMed Central PMCID: PMC129469.
  • Wilson MH, Highfield HA, Limbird LE. The role of a conserved inter-transmembrane domain interface in regulating alpha(2a)-adrenergic receptor conformational stability and cell-surface turnover. Mol Pharmacol. 2001 Apr;59(4):929-38. PubMed PMID: 11259639.
  • Wilson MH, Limbird LE. Mechanisms regulating the cell surface residence time of the alpha 2A-adrenergic receptor. Biochemistry. 2000 Feb 1;39(4):693-700. PubMed PMID: 10651634.
  • Wilson MH, Puranam RS, Ottman R, Gilliam C, Limbird LE, George AL Jr, McNamara JO. Evaluation of the alpha(2A)-adrenergic receptor gene in a heritable form of temporal lobe epilepsy. Neurology. 1998 Dec;51(6):1730-1. PubMed PMID: 9855534.